Bender Robert & Associates
LLY icon

Bender Robert & Associates’s Eli Lilly LLY Stock Holding History

Bender Robert & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,209
Closed -$16.5M – 63
2024
Q2 		$16.5M Buy
+18,209
New +$14.6M 3.62% 7

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Bender Robert & Associates's LLY Position: Q3 2026 in Review

Bender Robert & Associates reduced its Eli Lilly (LLY) stake by 0.28% in Q3 2026, selling an estimated $57.8K and leaving 17,595 shares worth $20.4M. The position accounts for 3.88% of the portfolio, ranked #8.

Bender Robert & Associates first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.2M in Q2 2026. 1,995 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Bender Robert & Associates held 17,595 shares of Eli Lilly worth $20.4M as of Q3 2026.
  • Bender Robert & Associates sold 49 Eli Lilly shares in Q3 2026, an estimated $57.8K.
  • Eli Lilly made up 3.88% of Bender Robert & Associates's portfolio in Q3 2026, its #8 holding.
  • Bender Robert & Associates first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • Bender Robert & Associates's Eli Lilly position peaked at $21.2M in Q2 2026.
  • 1,995 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Bender Robert & Associates's 13F filing for Q3 2026, filed 21 Oct 2026.